Skip to main content
Log in

First- and second-generation perfluorocarbon emulsions

  • Medicinal Plants
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This review addresses first- and second-generation perfluorocarbon emulsions, which are used as blood substitutes when the use of donor blood is problematic. The first perfluorocarbon preparations created as synthetic blood substitutes started to be used in Japan (Green Cross Corporation). These were the first-generation preparations Fluosol-DA 20%, Fluosol-DA 35%, and the Russian formulation Perftoran. The disadvantages of first-generation perfluorocarbon preparations were that they could not be sterilized, were unstable, and produced significant numbers of side effects. Second-generation emulsions include the American formulation Oxygent and the Russian formulations of the Ftoran series, which produce fewer side effects and can be rigorously sterilized and thawed quickly without alteration to their physicochemical or medical-biological properties. Further progress in creating artificial gas transporters and energy carriers based on fluoroorganic and organic compounds will lead to the wider use of emulsion nanosystems in many areas of medicine and biology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Yu. A. Ol’dekop and N. A. Maier, Introduction to Organoelemental Chemistry [in Russian], Vysshaya Shkola, Moscow (1973), pp. 32 – 35.

    Google Scholar 

  2. L. Clark and F. Gollan, Science, 152, 1752 – 1755 (1966).

    Article  Google Scholar 

  3. H. Sloviter and T. Kamimoto, Nature, 216, 1634 – 1638 (1967).

    Article  Google Scholar 

  4. R. Geyer, R. Monroe, and K. Taylor, Fed. Proc., 27, 384 (1968).

    Google Scholar 

  5. H. Makowski, P. Tentschev, P. Frey, et al., IV Internat. Symposium on Perfl. Blood Substitutes, Kyoto (1978), pp. 47 – 52.

  6. R. Naito and K. Yokohama, Research on Perfluorochemicals in Medicine and Biology, Symposium Proceedings, Stockholm (1977), p. 42.

  7. R. Naito, IV Internat. Symposium on Perfl. Blood Substitutes, Kyoto (1978), pp. 33 – 45.

  8. S. I. Vorob’ev, G. R. Ivanitskii, K. N. Makarov, et al., Perfluorocarbon Emulsions [in Russian], Department of Scientific and Technical Information, Russian Academy of Sciences, Pushchino, Preprint (1993).

  9. S. I. Vorob’ev, G. R. Ivanitskii, K. N. Makarov, et al., Physiological Activity of Fluorine-Containing Compounds (Experimental and Clinical Studies) [in Russian], Department of Scientific and Technical Information, Russian Academy of Sciences, Pushchino, pp. 33 – 41.

  10. S. I. Vorob’ev, G. R. Ivanitskii, V. V. Moroz, et al., Vestn. Intensiv. Terapii, No. 2 – 3, 15 – 21 (1996).

  11. S. I. Vorob’ev, G. R. Ivanitskii, K. N. Makarov, et al., Perftoran [in Russian], Department of Scientific and Technical Information, Russian Academy of Sciences, Pushchino (1997).

  12. J. Riess, Artificial Organs, 5, 253 – 258 (1991).

    Google Scholar 

  13. J. Riess, S. Flaim, and D. Rlein, Physiological Activity of Fluorine-Containing Compounds (Experimental and Clinical Studies) [in Russian], Department of Scientific and Technical Information, Russian Academy of Sciences, Pushchino (1995), pp. 73 – 90.

  14. T. Mitsuna, S. Tabuchi, and M. Ohyangi, Intern. Symp. on Perfluoroc. Blood Subst., Meinz (1981), p. 220.

  15. R. Naito and K. Yokoyama, Technical Inf. Series, 1, 134 – 135 (1975).

    Google Scholar 

  16. H. Sloviter. M. Petkovic, S. Ogoshi, et al., Fed. Proc., 2, 453 – 455 (1969).

    Google Scholar 

  17. H. Beisbarth and F. Suyama, Intern. Symp. on Perfluoroc. Blood Subst., Meinz (1981), p. 13.

  18. N. I. Afonin and G. Ya. Rozenberg, Probl. Gematol., 8, 49 – 53 (1979).

    Google Scholar 

  19. F. F. Beloyartsev, Perfluorinated Hydrocarbons in Biology and Medicine [in Russian], Department of Scientific and Technical Information, Russian Academy of Sciences, Pushchino (1980), pp. 19 – 28.

  20. H. S. Chen and Z. H. Yang, Biomater. Artif. Cells Artif. Organs, 16, 403 – 409 (1988).

    PubMed  CAS  Google Scholar 

  21. M. Blanc and J. Riess, Intern. Symp. on Perfluoroc. Blood Subst., Meinz (1981), p. 8.

  22. S. I. Vorob’ev, Author’s Abstract of Doctoral Thesis in Biological Sciences, Moscow (1994).

  23. S. I. Vorob’ev, V. A. Golovin, S. N. Davydova, et al., Vestn. Novykh Tekhnologii, 5(3 – 4), 84 – 88 (1998).

    Google Scholar 

  24. S. I. Vorob’ev, Ros. Zh. Anesteziol. Intensiv. Ter., 2, 18 – 24 (1999).

    Google Scholar 

  25. S. I. Vorob’ev, Author’s Abstract of Master’s Thesis in Biological Sciences, Moscow (1990).

  26. T. H. Goodin, Second Annual IBC Conference on blood Substitutes, Meinz (1994), pp. 12 – 14.

  27. R. F. Moore, Biomater. Artif. Cells and Artif. Organs,No. 1 – 3, 443 – 445 (1988).

  28. K. Yokoyama, R. Naito, Y. Tsuda, et al., Program Clin. Biol. Res., 122, 189 – 191 (1983).

    CAS  Google Scholar 

  29. K. K. Tremper, A. E. Friedman, and E. M. Levin, Med., 307, 277 – 283 (1982).

    CAS  Google Scholar 

  30. G. M. Vercellotti, D. E. Hammerschmidt, P. R. Craddock, et al., Blood, 59, 1299 – 1304 (1982).

    PubMed  CAS  Google Scholar 

  31. G. M. Vercellotti and D. E. Hammerschmidt, Int. Anent. Clinic, No. 1, 47 – 62 (1985).

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 43, No. 4, pp. 30 – 40, April, 2009.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vorob’ev, S.I. First- and second-generation perfluorocarbon emulsions. Pharm Chem J 43, 209–218 (2009). https://doi.org/10.1007/s11094-009-0268-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-009-0268-1

Key words

Navigation